Wetherill Leah, Schuckit Marc A, Hesselbrock Victor, Xuei Xiaoling, Liang Tiebing, Dick Danielle M, Kramer John, Nurnberger John I, Tischfield Jay A, Porjesz Bernice, Edenberg Howard J, Foroud Tatiana
Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.
Alcohol Clin Exp Res. 2008 Dec;32(12):2031-40. doi: 10.1111/j.1530-0277.2008.00790.x. Epub 2008 Sep 25.
Several lines of evidence in both human and animal studies suggest that variation in neuropeptide Y (NPY) or its receptor genes (NPY1R, NPY2R and NPY5R) is associated with alcohol dependence as well as alcohol withdrawal symptoms. Additional studies suggest that cocaine may affect NPY expression.
A total of 39 single nucleotide polymorphisms (SNPs) were genotyped across NPY and its 3 receptor genes in a sample of 1,923 subjects from 219 multiplex alcoholic families of European American descent recruited as part of the Collaborative Studies on the Genetics of Alcoholism (COGA) study. Family-based association analysis was performed to test the primary hypothesis that variation in these genes is associated with alcohol dependence. Secondary analyses evaluated whether there was an association of these SNPs with symptoms of alcohol withdrawal, cocaine dependence, or comorbid alcohol and cocaine dependence.
Although variations in NPY itself were not associated with these phenotypes, variations in 2 NPY-receptor genes were. SNPs in NPY2R provided significant evidence of association with alcohol dependence, alcohol withdrawal symptoms, comorbid alcohol and cocaine dependence, and cocaine dependence (all p < 0.03). Haplotype analyses strengthened the evidence for these phenotypes (global 0.0004 < p < 0.005). SNPs in NPY5R demonstrated significant association with alcohol withdrawal characterized by seizures (p < 0.05).
These results indicate that sequence variations in NPY receptor genes are associated with alcohol dependence, particularly a severe subtype of alcohol dependence characterized by withdrawal symptoms, comorbid alcohol and cocaine dependence, and cocaine dependence.
多项人体和动物研究的证据表明,神经肽Y(NPY)或其受体基因(NPY1R、NPY2R和NPY5R)的变异与酒精依赖以及酒精戒断症状有关。其他研究表明,可卡因可能会影响NPY的表达。
在作为酒精中毒遗传学合作研究(COGA)一部分招募的219个欧美裔多重酒精成瘾家庭的1923名受试者样本中,对NPY及其3个受体基因的总共39个单核苷酸多态性(SNP)进行了基因分型。进行基于家系的关联分析,以检验这些基因的变异与酒精依赖相关的主要假设。二级分析评估了这些SNP是否与酒精戒断症状、可卡因依赖或酒精和可卡因共病依赖有关。
尽管NPY本身的变异与这些表型无关,但2个NPY受体基因的变异有关。NPY2R中的SNP提供了与酒精依赖、酒精戒断症状、酒精和可卡因共病依赖以及可卡因依赖显著相关的证据(所有p<0.03)。单倍型分析加强了这些表型的证据(全局0.0004<p<0.005)。NPY5R中的SNP显示与以癫痫发作为特征的酒精戒断显著相关(p<0.05)。
这些结果表明,NPY受体基因的序列变异与酒精依赖有关,尤其是以戒断症状、酒精和可卡因共病依赖以及可卡因依赖为特征的严重酒精依赖亚型。